BofA Securities Maintains Cellebrite(CLBT.US) With Buy Rating
Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating
Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating, Announces Target Price $23
Cellebrite DI (CLBT) Gets a Buy From Craig-Hallum
Cellebrite DI Is Maintained at Buy by TD Cowen
Cellebrite DI Analyst Ratings
TD Cowen Maintains Cellebrite(CLBT.US) With Buy Rating, Raises Target Price to $23
Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating
Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating
Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating
Analysts Offer Insights on Technology Companies: Cellebrite DI (CLBT), Stratasys (SSYS) and Mitek Systems (MITK)
Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating
Analysts Are Bullish on These Technology Stocks: Cellebrite DI (CLBT), D-Wave Quantum (QBTS)
Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating
Deutsche Bank Maintains Cellebrite(CLBT.US) With Buy Rating, Raises Target Price to $18
Cellebrite DI Analyst Ratings
JPMorgan Adjusts Cellebrite DI Price Target to $17 From $15, Maintains Overweight Rating
Craig-Hallum Maintains Buy on Cellebrite DI, Raises Price Target to $20
A Quick Look at Today's Ratings for Cellebrite(CLBT.US), With a Forecast Between $17 to $17
Analysts Offer Insights on Technology Companies: Coherent Corp (COHR), Cellebrite DI (CLBT) and Grab (GRAB)